| Date Filed | Type | Description |
| 05/30/2023 |
4
| GLASSPOOL JOHN (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 92,958 options to buy
@ $3.37, valued at
$313.3k
|
|
| 12/20/2022 |
4
| GLASSPOOL JOHN (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 57,042 options to buy
@ $3.37, valued at
$192.2k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2020 |
3/A
| GLASSPOOL JOHN (Director) has filed a Form 3/A on RELMADA THERAPEUTICS, INC. |
| 01/06/2020 |
3
| GLASSPOOL JOHN (Director) has filed a Form 3 on RELMADA THERAPEUTICS, INC. |
| 06/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2016 |
4
| GLASSPOOL JOHN (See Remarks) has filed a Form 4 on Baxalta Inc|
Txns:
| Granted 15,259 shares
@ $0
Paid exercise price by delivering 859 shares
@ $39.3, valued at
$33.8k
Paid exercise price by delivering 161 shares
@ $39.47, valued at
$6.4k
|
|
| 02/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |